US Stock MarketDetailed Quotes

INBX Inhibrx Biosciences

Watchlist
  • 15.710
  • +0.160+1.03%
Close Nov 5 16:00 ET
227.42MMarket Cap0.13P/E (TTM)

Inhibrx Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
--226.86M
----
----
----
-Cash and cash equivalents
--226.86M
----
----
----
Receivables
--1.39M
--304K
202.72%778K
--257K
-Accounts receivable
--271K
--171K
220.16%778K
--243K
-Related party accounts receivable
--164K
----
--0
--14K
-Other receivables
--952K
--133K
----
----
Prepaid assets
--11.73M
--12.3M
117.42%11.59M
--5.33M
Other current assets
--2.08M
--1.58M
62.31%1.09M
--674K
Total current assets
--242.06M
--14.18M
114.99%13.47M
--6.26M
Non current assets
Net PPE
--9.62M
--9.7M
29.83%9.37M
--7.22M
-Gross PPE
--17.09M
--16.73M
25.87%16.06M
--12.76M
-Accumulated depreciation
---7.48M
---7.03M
-20.70%-6.69M
---5.54M
Related parties assets
--164K
----
--0
--14K
Non current prepaid assets
----
--4.34M
----
----
Other non current assets
--6.75M
----
0.00%3.16M
--3.16M
Total non current assets
--16.36M
--14.04M
20.74%12.54M
--10.38M
Total assets
--258.42M
--28.22M
56.20%26M
--16.65M
Liabilities
Current liabilities
Payables
--13.02M
--12.37M
91.37%8.31M
--4.34M
-accounts payable
--13.02M
--12.37M
91.37%8.31M
--4.34M
Current accrued expenses
--19.35M
--21.85M
42.77%15.98M
--11.2M
Current debt and capital lease obligation
--2.17M
--2.12M
10.91%2.06M
--1.86M
-Current capital lease obligation
--2.17M
--2.12M
10.91%2.06M
--1.86M
Current liabilities
--39.05M
--38.43M
58.21%32.86M
--20.77M
Non current liabilities
Long term debt and capital lease obligation
--0
--561K
-65.02%1.11M
--3.17M
-Long term capital lease obligation
--0
--561K
-65.02%1.11M
--3.17M
Total non current liabilities
--0
--561K
-65.02%1.11M
--3.17M
Total liabilities
--39.05M
--38.99M
41.88%33.97M
--23.95M
Shareholders'equity
Share capital
--1K
----
----
----
-common stock
--1K
----
----
----
-Preferred stock
--0
----
----
----
Retained earnings
---14.4M
----
----
----
Paid-in capital
--233.77M
----
----
----
Other equity interest
----
---10.77M
-9.22%-7.97M
---7.3M
Total stockholders'equity
--219.37M
---10.77M
-9.22%-7.97M
---7.3M
Total equity
--219.37M
---10.77M
-9.22%-7.97M
---7.3M
Currency Unit
USD
USD
USD
USD
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments --226.86M------------
-Cash and cash equivalents --226.86M------------
Receivables --1.39M--304K202.72%778K--257K
-Accounts receivable --271K--171K220.16%778K--243K
-Related party accounts receivable --164K------0--14K
-Other receivables --952K--133K--------
Prepaid assets --11.73M--12.3M117.42%11.59M--5.33M
Other current assets --2.08M--1.58M62.31%1.09M--674K
Total current assets --242.06M--14.18M114.99%13.47M--6.26M
Non current assets
Net PPE --9.62M--9.7M29.83%9.37M--7.22M
-Gross PPE --17.09M--16.73M25.87%16.06M--12.76M
-Accumulated depreciation ---7.48M---7.03M-20.70%-6.69M---5.54M
Related parties assets --164K------0--14K
Non current prepaid assets ------4.34M--------
Other non current assets --6.75M----0.00%3.16M--3.16M
Total non current assets --16.36M--14.04M20.74%12.54M--10.38M
Total assets --258.42M--28.22M56.20%26M--16.65M
Liabilities
Current liabilities
Payables --13.02M--12.37M91.37%8.31M--4.34M
-accounts payable --13.02M--12.37M91.37%8.31M--4.34M
Current accrued expenses --19.35M--21.85M42.77%15.98M--11.2M
Current debt and capital lease obligation --2.17M--2.12M10.91%2.06M--1.86M
-Current capital lease obligation --2.17M--2.12M10.91%2.06M--1.86M
Current liabilities --39.05M--38.43M58.21%32.86M--20.77M
Non current liabilities
Long term debt and capital lease obligation --0--561K-65.02%1.11M--3.17M
-Long term capital lease obligation --0--561K-65.02%1.11M--3.17M
Total non current liabilities --0--561K-65.02%1.11M--3.17M
Total liabilities --39.05M--38.99M41.88%33.97M--23.95M
Shareholders'equity
Share capital --1K------------
-common stock --1K------------
-Preferred stock --0------------
Retained earnings ---14.4M------------
Paid-in capital --233.77M------------
Other equity interest -------10.77M-9.22%-7.97M---7.3M
Total stockholders'equity --219.37M---10.77M-9.22%-7.97M---7.3M
Total equity --219.37M---10.77M-9.22%-7.97M---7.3M
Currency Unit USDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Recent IPOs
Recent IPOs
Intraday+0.09%